[Central monoaminergic mechanisms and generalized convulsions (review)].
D006916:5-Hydroxytryptophan / Q000627:therapeutic use; D000661:Amphetamine / Q000627:therapeutic use; D000818:Animals; D000927:Anticonvulsants / Q000627:therapeutic use; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism; D002540:Cerebral Cortex / Q000378:metabolism; D004295:Dihydroxyphenylalanine / Q000378:metabolism; D004298:Dopamine / Q000378:metabolism; D000882:Haplorhini; D006624:Hippocampus / Q000378:metabolism; D008781:Methyltyrosines / Q000378:metabolism; D009638:Norepinephrine / Q000378:metabolism; D011817:Rabbits; D051381:Rats; D012154:Reticular Formation / Q000378:metabolism; D012640:Seizures / Q000139:chemically induced / Q000188:drug therapy / Q000378:metabolism*; D012701:Serotonin / Q000378:metabolism
D000927:Anticonvulsants; D001679:Biogenic Amines; D008781:Methyltyrosines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D000661:Amphetamine; D004298:Dopamine; D009638:Norepinephrine
Tsentral'nye monoaminergicheskie mekhanizmy i generalizovannye sudorogi (obzor)